Prostate Cancer Essay

Prostate cancer is the second most common cancer and it is the second leading cause of cancer death in American men according to the American Cancer Society(ACS) ( 2016). Older age is the strongest risk factor for the development of prostate cancer. Approximately 1 in 7 men will be diagnosed with prostate cancer during his lifetime (ACS, 2016). There are more than 2.9 million prostate cancer survivors in the United States (ACS, 2016). The risk of dying from prostate cancer is 2.9 percent, with seventy

Each year approximately 233,000 men will be diagnosed with prostate cancer (Eggener, Cifu, & Nabhan, 2015). In 2015, prostate cancer was the second most common cancer related cause of death among United States men (Eggener, et. al., 2015). While the majority of prostate cancers are slow growing with a 5-year survival rate of approximately 98%, statistics show that when prostate cancer is identified as metastatic, the 5-year survival rate dramatically drops down to 20-25% (Eggener, et. al., 2015)

Prostate cancer is the most common cancer in American men aside from skin cancer. Out of six American men at least one of them will be diagnosed with colon cancer. The prostate is a small gland shaped like a walnut that is in the center of a man 's body within the pelvis. The prostate makes a milky fluid that carries sperm during ejaculation. It is wrapped around the tube that carries urine out of the body (the urethra). It sits just below the bladder. Prostate cancer is more common in African American

In the early stages, symptoms indicating that prostate cancer may have developed are rarely seen, but there are some clinical signs and symptoms that can help determine the presence of this cancer. A neoplasm is a new and abnormal growth of tissue in some part of the body. “If the neoplasm is large enough to encroach on the bladder neck, signs and symptoms of urinary obstruction occur (difficulty and frequency of urination, urinary retention, and decreased size and force of the urinary stream)”

diagnose for prostate cancer. He is tasked with performing numerous tests to verify the accurateness of the medical devices detecting prostate cancer since some medical devices are prone to have questionable results. During his research, he notices an alarming change in a specific patient results and is unsure of how to interpret the results. His uncertainty is due to the patients’ results changing from being consistently negative to being consistently positive for early stage prostate cancer. Milo monitors

Prostate cancer treatment is explored by three different solutions: surgical, radiation, and hormonal treatment. The surgical removal of prostate cancer has for many years been the most common treatment of the disease. (Fuller, 2006) This process has been very controversial. Many argue that surgery is the only real solution for permanently curing prostate cancer. Other challengers claim that the central influence of surgery is to produce incontinence and impotence without any clear evidence, compared

Prostate cancer, what’s the big deal? It’s treatable right? So many famous people have been diagnosed and they seem to be OK, right? Plus, nobody actually dies of prostate cancer, right? Wrong. It’s estimated that over 28,000 lives will be lost this year to Prostate cancer in the U.S. alone. Let’s put this into perspective: people always say flying is a safe way to travel causing only 469 deaths per year. This is especially true in comparison to driving which causes 35,080 deaths per year. In most

Prostate cancer is considered as the most commonly diagnosed cancer in men, in the U. S and most cases of prostate cancer have a good prognosis. Some of these cases can be aggressive and the death-rate is assessed to be 2.8%. The Prostate-specific antigen (PSA) test is used for screening for prostate cancer, to aid early detection and treatment. Prostate-specific antigen (PSA) test Prostate-specific antigen (PSA) is a protein produced by the prostate gland, found in the blood. Blood sample

Nanotechnology for prostate cancer Ming Gao NEU ID: 001983161 NNMD 5270 Introduction to Nanomedicine Science and Technology Professor Srinivas Sridhar Dr. Anne L. van de Ven Northeastern University 12/08/2014   Introduction Prostate cancer (PCa), the development of cancer in the prostate, is one of the most mortal diseases that threaten men’s lives in current world. It is the most commonly diagnosed non-skin cancer in the United States, and it is second leading cause of cancer deaths in American

Prostate cancer is the most common type of carcinoma and the second leading cause of cancer death in men, following carcinoma of the lung. The risk of developing prostate cancer increases with age, beginning at age 50, and is also higher among African-American men. The two highest age subpopulations diagnosed are men 55-64 and 65-74 years of age, comprising 29.0% and 35.6% of all prostate cancer diagnoses, respectively. The age-adjusted incidence rate of prostate cancer is 159.3 per 100,000 men